Patients feel engaged, supported by mHealth after outpatient surgery

Patients who used a mobile health (mHealth) application for follow-ups on post-operative recovery felt engaged and supported, according to a study published May 25 in JMIR mHealth and uHealth.

As outpatient surgery has become a more popular option, patients are forced to take their postoperative recovery into their own hands. Researchers aimed to test the feasibility in using mHealth to support patients and improve recovery following outpatient surgery.

“Recovery can be a time-consuming process that affects the patient’s physical and psychological status and includes regaining their preoperative social, habitual, psychological and physical functions,” wrote first author Karuna Dahlberg, RN, MSc, and colleagues. “As most of the recovery occurs outside the hospital after day surgery, self-care can be a central part of recovery. However, it has been reported that patients can feel lonely and unsure about how the recovery is proceeding and some feel that there was a lack of support after discharge.”

Researchers interviewed 18 patients who had undergone outpatient surgery and used the Recovery Assessment by Phone Points mHealth app to follow-up on recovery. Patients reported two themes when using the app: it’s important to use it as much as possible and it will help feelings of safety.

“It is important that patients feel safe, reassured, and acknowledged during their postoperative recovery,” concluded Dahlaberg and colleagues. “They can achieve this themselves with sufficient support and information from the health care organization and their next of kin. Using a mobile app, both for assessment and to enable contact with the day surgery unit during the postoperative recovery period, can improve care and create a feeling of not being alone after surgery. We propose that postoperative recovery starts in the pre-recovery phase when patients prepare for their recovery to get the best possible outcome from their surgery.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.